TLRY
Price
$0.42
Change
+$0.01 (+2.44%)
Updated
Jul 1 closing price
Capitalization
1.87B
21 days until earnings call
VTRS
Price
$9.18
Change
+$0.25 (+2.80%)
Updated
Jul 1 closing price
Capitalization
14.18B
36 days until earnings call
Interact to see
Advertisement

TLRY vs VTRS

Header iconTLRY vs VTRS Comparison
Open Charts TLRY vs VTRSBanner chart's image
Tilray Brands
Price$0.42
Change+$0.01 (+2.44%)
Volume$10.12M
Capitalization1.87B
Viatris
Price$9.18
Change+$0.25 (+2.80%)
Volume$17.39M
Capitalization14.18B
TLRY vs VTRS Comparison Chart in %
Loading...
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TLRY vs. VTRS commentary
Jul 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TLRY is a Buy and VTRS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 02, 2025
Stock price -- (TLRY: $0.41 vs. VTRS: $8.93)
Brand notoriety: TLRY: Notable vs. VTRS: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TLRY: 72% vs. VTRS: 63%
Market capitalization -- TLRY: $1.87B vs. VTRS: $14.18B
TLRY [@Pharmaceuticals: Other] is valued at $1.87B. VTRS’s [@Pharmaceuticals: Other] market capitalization is $14.18B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TLRY’s FA Score shows that 0 FA rating(s) are green whileVTRS’s FA Score has 2 green FA rating(s).

  • TLRY’s FA Score: 0 green, 5 red.
  • VTRS’s FA Score: 2 green, 3 red.
According to our system of comparison, VTRS is a better buy in the long-term than TLRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TLRY’s TA Score shows that 4 TA indicator(s) are bullish while VTRS’s TA Score has 4 bullish TA indicator(s).

  • TLRY’s TA Score: 4 bullish, 3 bearish.
  • VTRS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TLRY is a better buy in the short-term than VTRS.

Price Growth

TLRY (@Pharmaceuticals: Other) experienced а +14.95% price change this week, while VTRS (@Pharmaceuticals: Other) price change was +0.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.53%. For the same industry, the average monthly price growth was +79.97%, and the average quarterly price growth was +68.03%.

Reported Earning Dates

TLRY is expected to report earnings on Jul 23, 2025.

VTRS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VTRS($14.2B) has a higher market cap than TLRY($1.87B). VTRS has higher P/E ratio than TLRY: VTRS (238.80) vs TLRY (8.52). VTRS YTD gains are higher at: -26.330 vs. TLRY (-68.842). VTRS has higher annual earnings (EBITDA): 3.52B vs. TLRY (-1.23B). VTRS has more cash in the bank: 1.18B vs. TLRY (260M). TLRY has less debt than VTRS: TLRY (529M) vs VTRS (18.4B). VTRS has higher revenues than TLRY: VTRS (15.4B) vs TLRY (700M).
TLRYVTRSTLRY / VTRS
Capitalization1.87B14.2B13%
EBITDA-1.23B3.52B-35%
Gain YTD-68.842-26.330261%
P/E Ratio8.52238.804%
Revenue700M15.4B5%
Total Cash260M1.18B22%
Total Debt529M18.4B3%
FUNDAMENTALS RATINGS
TLRY vs VTRS: Fundamental Ratings
TLRY
VTRS
OUTLOOK RATING
1..100
460
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
14
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9694
PRICE GROWTH RATING
1..100
9459
P/E GROWTH RATING
1..100
951
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTRS's Valuation (14) in the null industry is somewhat better than the same rating for TLRY (47) in the Biotechnology industry. This means that VTRS’s stock grew somewhat faster than TLRY’s over the last 12 months.

VTRS's Profit vs Risk Rating (100) in the null industry is in the same range as TLRY (100) in the Biotechnology industry. This means that VTRS’s stock grew similarly to TLRY’s over the last 12 months.

VTRS's SMR Rating (94) in the null industry is in the same range as TLRY (96) in the Biotechnology industry. This means that VTRS’s stock grew similarly to TLRY’s over the last 12 months.

VTRS's Price Growth Rating (59) in the null industry is somewhat better than the same rating for TLRY (94) in the Biotechnology industry. This means that VTRS’s stock grew somewhat faster than TLRY’s over the last 12 months.

VTRS's P/E Growth Rating (1) in the null industry is significantly better than the same rating for TLRY (95) in the Biotechnology industry. This means that VTRS’s stock grew significantly faster than TLRY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TLRYVTRS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
56%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
63%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
61%
Advances
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
67%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 2 days ago
66%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
56%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Interact to see
Advertisement
TLRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QTOP28.250.30
+1.07%
iShares Nasdaq Top 30 Stocks ETF
PJBF61.010.41
+0.67%
PGIM Jennison Better Future ETF
BNO29.190.08
+0.27%
United States Brent Oil
MUNI51.360.08
+0.16%
PIMCO Intermediate Municipal Bd Actv ETF
FNY82.440.05
+0.06%
First Trust Mid Cap Growth AlphaDEX® ETF

TLRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TLRY has been loosely correlated with CGC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if TLRY jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLRY
1D Price
Change %
TLRY100%
+3.42%
CGC - TLRY
63%
Loosely correlated
-0.81%
OGI - TLRY
61%
Loosely correlated
N/A
CRON - TLRY
61%
Loosely correlated
+0.53%
ACB - TLRY
56%
Loosely correlated
+2.17%
VTRS - TLRY
35%
Loosely correlated
-0.89%
More

VTRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTRS has been loosely correlated with ZTS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if VTRS jumps, then ZTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTRS
1D Price
Change %
VTRS100%
-0.89%
ZTS - VTRS
43%
Loosely correlated
-0.14%
AMRX - VTRS
42%
Loosely correlated
-0.49%
ELAN - VTRS
41%
Loosely correlated
-0.07%
PAHC - VTRS
39%
Loosely correlated
-0.47%
PBH - VTRS
36%
Loosely correlated
-1.30%
More